Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Clinical trial NCT05266417 · RECRUITING
Trial details
- NCT number
- NCT05266417
- Sponsor
- Gateway Institute for Brain Research
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2027-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.